IMS data showed Gilead Sciences (NASDAQ: GILD) showed Harvoni scripts were up week-over-week and Sovaldi prescriptions were up, Leerink Parnters ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE